Skip to main content
OpenTrials

Clinical trial condition

Metastatic Head and Neck Cancer

Explore clinical trials studying Metastatic Head and Neck Cancer. Study availability and eligibility vary by location and protocol.

13 public trials 4 recruiting studies
Refine in advanced search Browse all conditions

Metastatic Head and Neck Cancer trial results

Recruiting

A Clinical Trial Investigating the Safety, Tolerability, and Therapeutic Effects of BNT113 in Combination With Pembrolizumab Versus Pembrolizumab Alone for Patients With a Form of Head and Neck Cancer Positive for Human Papilloma Virus 16 and Expressing the Protein PD-L1

NCT04534205

Conditions
Carcinoma, Carcinoma, Squamous Cell, Disease Attributes, +14 more
Locations
  • California Research Institute Los Angeles, California, United States
  • UCLA Cancer Care Los Angeles, California, United States
  • Stanford Cancer Institute Palo Alto, California, United States
  • Yale University New Haven, Connecticut, United States
View all 195 locations
View Trial Details
Recruiting

Cetuximab Plus Platinum and Taxane-based Chemotherapy, Followed by Avelumab and Cetuximab, as First-line Treatment for Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma (HNSCC) Patients With a PD-L1 Combined Positive Score (CPS)≥1≤19.

NCT06869473

Conditions
Carcinoma, Carcinoma, Squamous Cell, Head and Neck Neoplasms, +9 more
Locations
  • Ospedale Oncologico "A. Businco" ARNAS BROTSU Cagliari, CAGLIARI, Italy
  • Azienda Ospedaliero-Universitaria Policlinico "G. Rodolico-S. Marco Catania, CATANIA, Italy
  • Azienda Ospedaliero-Universitaria Careggi Florence, FIRENZE, Italy
  • Fondazione IRCCS Istituto Nazionale dei Tumori (INT) di Milano Milan, Milano, Italy
View Trial Details
Completed

Study of PDS0101 and Pembrolizumab Combination I/O in Subjects With HPV16 + Recurrent and/or Metastatic HNSCC

NCT04260126

Conditions
Carcinoma, Carcinoma, Squamous Cell, HPV Positive Oropharyngeal Squamous Cell Carcinoma, +9 more
Locations
  • Marin Cancer Center Greenbrae, California, United States
  • University of California San Francisco San Francisco, California, United States
  • Mayo Clinic Jacksonville, Florida, United States
  • Cleveland Clinic Florida Weston, Florida, United States
View all 23 locations
View Trial Details
Completed

A Phase II, Open-Label, Multicenter Trial of Cabazitaxel in Patients With Recurrent or Metastatic Head and Neck Cancer After Failure Of Cisplatin, Cetuximab and Taxanes

NCT01620242

Conditions
Disease Attributes, Head and Neck Neoplasms, Metastatic Head and Neck Cancer, +6 more
Locations
  • Centre Oscar Lambret Lille, France
  • Centre Léon Berard Lyon, France
  • Centre Antoine Lacassagne Nice, France
  • Institut Curie Paris, France
View Trial Details

Related conditions